Loading insider details...
Latest Form 4 (Oct 6, 2026): Sale of 1,333 RGEN shares, $238.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | REPLIGEN CORP (RGEN) | Sale | 1,333 | $238.3K |
| Oct 5, 2026 | REPLIGEN CORP (RGEN) | Tax Withholding | 1,248 | $226.8K |
| Sep 25, 2026 | REPLIGEN CORP (RGEN) | Exercise/Conversion | 8,404 | $1.30M |
| Sep 22, 2026 | REPLIGEN CORP (RGEN) | Exercise/Conversion | 5,426 | $769.4K |
| Sep 8, 2026 | REPLIGEN CORP (RGEN) | Tax Withholding | 2,842 | $482.0K |
| Aug 21, 2026 | REPLIGEN CORP (RGEN) | Exercise/Conversion | 5,426 | $769.4K |
| Apr 22, 2026 | REPLIGEN CORP (RGEN) | Sale | 3,832 | $536.5K |
| Mar 23, 2026 | REPLIGEN CORP (RGEN) | Grant/Award | 24,134 | n/a |
| Mar 3, 2026 | REPLIGEN CORP (RGEN) | Tax Withholding | 344 | $44.3K |
| Nov 26, 2025 | REPLIGEN CORP (RGEN) | Sale | 7,041 | $1.20M |